Skip to main content
Clinical Trials/ACTRN12608000195358
ACTRN12608000195358
Completed
Phase 4

The effects of intra-articular Sodium Hyaluronate Injection after Arthroscopic Débridement for Osteoarthritis of the Knee evaluated by pain and physical scales: A Prospective, Randomized, Controlled Study

Hacettepe University0 sites80 target enrollmentApril 14, 2008

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
osteoarthritis
Sponsor
Hacettepe University
Enrollment
80
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 14, 2008
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • age between 40\-65 years, symptomatic primary knee OA according to American College of Rheumatology criteria with a Kellgren\-Lawrence (K\-L) severity grade of level II or III as determined radiographically at screening.

Exclusion Criteria

  • Patients who refused to provide the written informed consent for taking part in the study, agreed to follow study procedures and attend all study visits.
  • Patients with previously known bleeding diathesis or coagulation disorder,
  • Patients who have any form of contraindication for an arthroscopy procedure,
  • Patients with known allergies against chicken or chicken products for intra\-articular sodium hyaluronate injection,
  • Patients with secondary arthritis, like rheumatoid arthritis or suspected to have any other form of an inflammatory arthritis,
  • Patients in whom microfracture” technique was used during AD,
  • Patients with major frontal plane deformities,
  • Patients with patellar disorder or quadriceps mechanism disorders,
  • Patients with advanced level of mental handicap preventing them from fulfilling the study requirements.

Outcomes

Primary Outcomes

Not specified

Similar Trials